Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities

Davis, Ryan J., Welcker, Markus, Clurman, Bruce E.·2014·Cancer Cell
DOI 10.1016/j.ccell.2014.09.013

Cited by (347)

Items 301–347 of 347

  1. Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab
    Viola Bianca Serio, Tommaso Regoli, Debora Maffeo, Ignazio Martellucci, Diletta Rosati, Marco Ghisalberti, Alberto Balistreri, Gianluca Santamaria, Niccolò Vono, Francesca Mari et al. · 2026 · International Journal of Molecular Sciences
  2. Genomic Heterogeneity of Aggressive Pediatric and Adult Diffuse Astrocytomas
    Christopher R. Pierson, Diana Thomas · 2021 · Molecular pathology library
  3. Different miRNAs Related to FBXW7 Mutations or High Mitotic Indices Contribute to Rectal Neuroendocrine Tumors: A Pilot Study
    Ho Suk Kang, Ha Young Park, Hyun Kyung Lim, Il Tae Son, Min-Jeong Kim, Nan Young Kim, Min Jeong Kim, Eun Sook Nam, Seong Jin Cho, Mi Jung Kwon · 2023 · International Journal of Molecular Sciences
  4. FAM83D promotes the progression of 4NQO-induced esophageal carcinoma via inhibiting FBWX7
    Jinjin Li, Jianbing Tian, Ming Ma, Zhiruo Qin, Bingji Cao, Jiangshuo Yang, Xuexiao Wang, Xingxiao Yang · 2024 · Experimental Cell Research
  5. FBXW7 is a multifaceted regulator of the innate immune response to DNA viruses
    Xue-Dan Sun, Jiali Wang, Xin-yu Zhang, Zi-Lun Ruan, Wei Liang, Yi Guo, Wen-Kai Guan, Qing Yang, Ling Li, Hong‐Bing Shu et al. · 2025 · Cellular and Molecular Immunology
  6. FBXW7β isoform drives transcriptional activation of a proinflammatory TNF cluster in normal and malignant pro-B cells
    Scarlett Y. Yang, Katharina E. Hayer, Hossein Fazelinia, Lynn A. Spruce, Mukta Asnani, Kathryn L. Black, Ammar S. Naqvi, Vinodh Pillai, Yoseph Barash, Kojo S.J. Elenitoba‐Johnson et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Characterization of F-box proteins and their target substrates in cancer
    Hwee‐Fang Ng · 2014 · Figshare
  8. HSF Supports Cancer
    Makoto Chuma · 2016 · Springer eBooks
  9. Are Micrornas the Answer to Colorectal Cancer’s Big Questions?
    Anne E Sarver Subbaya · 2015 · Journal of Clinical & Experimental Pathology
  10. FBXW7 Pathway Functions as a Promising Therapeutic Target of Cholangiocarcinoma
    Hui Yang, Lili Chen · 2016 · Chemotherapy Open access
  11. A Drosophila melanogaster poszt-meiotikus spermatogenezisében szerepet játszó gének vizsgálata
    Viktor Vedelek · 2017
  12. Targeting the Ubiquitin-Dependent Transcriptional and Epigenetic Landscape in Cancer
    Emily Avitan‐Hersh, Amir Orian · 2017 · Current Pharmacology Reports
  13. The Molecular Pathology of Serous Endometrial Cancer
    Mary Ellen Urick, Meghan L. Rudd, Daphne W. Bell · 2017 · Molecular pathology library
  14. Genetic alterations in Adult T cell leukemia
    Chien‐Hung Yeh · 2017 · KU ScholarWorks (The University of Kansas)
  15. Cooperating Oncogenic Alterations in Aggressive Pten-Deficient Breast Cancer
    Sharon Wang · 2017 · TSpace (University of Toronto)
  16. c-Myc Metabolic Addiction in Cancers Counteracted by Resveratrol and NQO2
    Tze‐chen Hsieh, Barbara B. Doonan, JOSEPH M. WU · 2019 · IntechOpen eBooks
  17. E3-mediated Ubiquitin and Ubiquitin-like Protein Ligation: Mechanisms and Chemical Probes
    David T. Krist, Brenda Arlene Schulman · 2020 · Royal Society of Chemistry eBooks
  18. LSD1 Destabilizes FBXW7 Independent of Its Demethylase Activity
    Huiyin Lan, Mingjia Tan, Qiang Zhang, Fei Yang, Hua Li, Xiufang Xiong, Yi Sun · 2018 · SSRN Electronic Journal
  19. Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer
    Archana vasuki, Jemmy Christy · 2021 · Research Square
  20. FBXW7 triggers degradation of WDR5 to prevent mitotic slippage
    Simon Hänle-Kreidler, Kai T. Richter, Ingrid Hoffmann · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Data from Loss of FBXW7 Correlates with Increased IDH1 Expression in Glioma and Enhances IDH1-Mutant Cancer Cell Sensitivity to Radiation
    Zhuo Yang, Nan Hu, Weiwei Wang, Weihua Hu, Shaolong Zhou, Jianxiang Shi, Minghe Li, Zhou Jing, Chao Chen, Xuyang Zhang et al. · 2023
  22. Loss of the cyclin kinase inhibitor p27kip1 opens a therapeutic window by deregulating pathway choice after DNA double strand breaks
    Nisar P. Malek, Przemyslaw M. Bozko, Khắc Cường Bùi, Mohammad Rahbari, Sven Mattern, Pavlos Missios, Mihály Sulyok, Maria Garcia Beccaria, Mirian Fernandez, Stephanie K. Roessler et al. · 2023 · Research Square
  23. Recurrent FBXW7 mutations bypass Wnt/β-catenin addiction in cancer
    Zheng Zhong, David M. Virshup · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Nephronophthisis-associated FBW7 mediates cyst-dependent decline of renal function in ADPKD
    Maulin Mukeshchandra Patel, Vasileios Gerakopoulos, Eleni Petsouki, Kurt A. Zimmerman, Leonidas Tsiokas · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. MAPK dependent regulation of FBXW7 phosphodegrons
    Neha Singh · 2023 · Eötvös Loránd Tudományegyetem
  26. Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin‐3 Levels
    Mary Ellen Urick, Suresh Kumar Chalapareddy, Eun‐Jeong Yu, Daphne W. Bell · 2025 · Cancer Medicine
  27. Nuclear shuttling of CDC4 mediated broad-spectrum antiviral activity against diverse coronaviruses
    Mingwei Li, Yang Wu, Jin Tian, Qian Yang, Mingze Gao, Yongrui Wang, Xuepeng Wang, Ju Zhang, Yudi Pan, Hongyan Shi et al. · 2025 · Emerging Microbes & Infections
  28. Additional file 1 of USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
    Juntae Kwon, Zhang, Jinmin, Boram Mok, Samuel Allsup, Kim, Chul, Toretsky, Jeffrey, Cecil Han · 2023 · Figshare
  29. Additional file 1 of METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
    Wu, Yingtong, Chang, Ning, Zhang, Yong, Zhang, Xinxin, Leidi Xu, Yinggang Che, Qiao, Tianyun, Wu, Bin, Zhou, Ying, Jiang, Jun et al. · 2021 · Figshare
  30. Additional file 2 of USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
    Juntae Kwon, Zhang, Jinmin, Boram Mok, Samuel Allsup, Kim, Chul, Toretsky, Jeffrey, Cecil Han · 2024 · Figshare
  31. Additional file 3 of USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
    Juntae Kwon, Zhang, Jinmin, Boram Mok, Samuel Allsup, Kim, Chul, Toretsky, Jeffrey, Cecil Han · 2024 · Figshare
  32. Additional file 4 of USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
    Juntae Kwon, Zhang, Jinmin, Boram Mok, Samuel Allsup, Kim, Chul, Toretsky, Jeffrey, Cecil Han · 2024 · Figshare
  33. Additional file 5 of USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
    Juntae Kwon, Zhang, Jinmin, Boram Mok, Samuel Allsup, Kim, Chul, Toretsky, Jeffrey, Cecil Han · 2024 · Figshare
  34. Additional file 2 of METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
    Wu, Yingtong, Chang, Ning, Zhang, Yong, Zhang, Xinxin, Leidi Xu, Yinggang Che, Qiao, Tianyun, Wu, Bin, Zhou, Ying, Jiang, Jun et al. · 2021 · Figshare
  35. CRISPR-enabled genetic screens identify synthetic lethal targets across frequently altered cancer drivers
    Jessica Desjardins, Julian Bowlan, Cynthia Bernier, Srishti Jain, Théo Goullet de Rugy, David Gallo, Mark E. Orcholski, Nancy Laterreur, Abira Rajah, Joshua Miller et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  36. FBXW7 mutations reprogram glucose metabolism by activating the ETV6-GLUT1 axis
    Siqi Fei, Xiayun Xu, Tingrui Wang, Xinyue Jiang, Hanrong Zhu, Yingji Chen, Renjie Yuan, Zeheng Lv, Zhijian Gao, Huanxin Liu et al. · 2026 · Molecular Cancer
  37. Refined USP25/28 inhibitors with enhanced selectivity towards c-Myc driven squamous lung cancer cells
    Adán Pinto-Fernández, Claire Heride, A.P. Turnbull, Dora C. S. Pedroso, Victoria Smith, Lisa Mullee, Wojciech W. Krajewski, Cameron Bell, Anthony C. Varca, Thomas M. Charlton et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Multi-omics analysis identifies FBXW7 downregulation in hypertensive aorta with experimental validation
    Qiang Zhao, Ruixue Guo, Xuemei Fan, Jie Xu, Pengchong Dong, Shasha Gong, Ruiqin Xie, Libo Su, Jidong Zhang · 2026 · Journal of Radiation Research and Applied Sciences
  39. The multidimensional biology of SKP2: mechanisms, pathologies, and emerging therapeutic frontiers
    Tao Hou, Xiangmei Hua, Peiqiang Yan, Wei Ni, Jingchao Wang, Hiroyuki Inuzuka, David K. Simon, Wenyi Wei · 2026 · Acta Materia Medica
  40. GSK3β-FBXW7 axis regulates MAFB protein stability through ubiquitin-mediated proteasome degradation
    Sangita Chowdhury, Prasannajit Sahoo, Agniv Shome, Swati Srivastava, Vishal Upadhyay, Shivkant Mishra, A.K. Trivedi · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  41. E3 ubiquitin ligases orchestrate chemo-resistance in gastrointestinal malignancies: from DNA damage response to therapeutic targeting
    Teng Ma, 周永宁, Xiaojun Li, Junhong Guan · 2026 · Frontiers in Oncology
  42. Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations
    Jessica Desjardins, Julian Bowlan, Cynthia Bernier, Srishti Jain, Théo Goullet de Rugy, David Gallo, Mark E. Orcholski, Nancy Laterreur, Abira Rajah, Joshua Miller et al. · 2026 · Cell Reports
  43. SND1 promotes colorectal cancer progression and metastasis by stabilizing HK2 through the inhibition of FBW7-mediated ubiquitination
    Haoran Zhang, Jinlin Nie, Na Li, Zhen Bao, Tianjie Chen, Yong Yang, Hailiang Li · 2026 · International Immunopharmacology
  44. Recalibrating the apoptotic threshold: Ubiquitin‐regulated ER stress signalling in colorectal cancer
    Jing Hu, Shanliang Zheng, Ying Hu · 2026 · Clinical and Translational Discovery
  45. Ubiquitin signaling in tumor-associated macrophage reprogramming: mechanisms and therapeutic opportunities in cancers
    Xudong Li, Yaomei Wang, Ruochen Xu, Ziheng Qian, Meimei Yan, Mengya Gao, Zexing Liu, Yun Zhai, Lijie Wang, Yushan Cui et al. · 2026 · Biomarker Research
  46. BindingDB Entry 50018524: Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.
    BindingDB · 2024 · UC San Diego
  47. Molecular mechanisms of microRNA-92b during tumor progression and metastasis
    Amirhosein Maharati, Meysam Moghbeli · 2026 · Cancer Treatment and Research Communications